EN বাং
Lubilax

Lubilax

Capsule

🧬 Lubiprostone 🏭 Beacon Pharmaceuticals PLC
GENERIC NAME
Lubiprostone
MANUFACTURER
Beacon Pharmaceuticals PLC
UNIT PRICE
Unit Price: ৳ 15.05 (3 x 10: ৳ 451.50) Strip Price: ৳ 150.50
Indications
Pharmacology
Dosage & Administration
Interaction
Contraindications
Side Effects
Pregnancy & Lactation
Precautions & Warnings
Pediatric Usage
Storage Conditions

Indications

Chronic Idiopathic Constipation: Lubilax is indicated for the treatment of chronic idiopathic constipation in adults.

Opioid-induced Constipation: Lubilax is indicated for the treatment of opioid-induced constipation in adults.

Irritable Bowel Syndrome with Constipation: Lubilax is the only FDA approved drug for the treatment of irritable bowel syndrome with constipation in women >18 years old.

Pharmacology

Chronic Idiopathic Constipation: Lubilax is indicated for the treatment of chronic idiopathic constipation in adults.

Opioid-induced Constipation: Lubilax is indicated for the treatment of opioid-induced constipation in adults.

Irritable Bowel Syndrome with Constipation: Lubilax is the only FDA approved drug for the treatment of irritable bowel syndrome with constipation in women >18 years old.

Dosage & Administration

Chronic Idiopathic Constipation: Lubilax is indicated for the treatment of chronic idiopathic constipation in adults.

Opioid-induced Constipation: Lubilax is indicated for the treatment of opioid-induced constipation in adults.

Irritable Bowel Syndrome with Constipation: Lubilax is the only FDA approved drug for the treatment of irritable bowel syndrome with constipation in women >18 years old.

Interaction

Chronic Idiopathic Constipation: Lubilax is indicated for the treatment of chronic idiopathic constipation in adults.

Opioid-induced Constipation: Lubilax is indicated for the treatment of opioid-induced constipation in adults.

Irritable Bowel Syndrome with Constipation: Lubilax is the only FDA approved drug for the treatment of irritable bowel syndrome with constipation in women >18 years old.

Contraindications

Chronic Idiopathic Constipation: Lubilax is indicated for the treatment of chronic idiopathic constipation in adults.

Opioid-induced Constipation: Lubilax is indicated for the treatment of opioid-induced constipation in adults.

Irritable Bowel Syndrome with Constipation: Lubilax is the only FDA approved drug for the treatment of irritable bowel syndrome with constipation in women >18 years old.

Side Effects

Chronic Idiopathic Constipation: Lubilax is indicated for the treatment of chronic idiopathic constipation in adults.

Opioid-induced Constipation: Lubilax is indicated for the treatment of opioid-induced constipation in adults.

Irritable Bowel Syndrome with Constipation: Lubilax is the only FDA approved drug for the treatment of irritable bowel syndrome with constipation in women >18 years old.

Pregnancy & Lactation

Chronic Idiopathic Constipation: Lubilax is indicated for the treatment of chronic idiopathic constipation in adults.

Opioid-induced Constipation: Lubilax is indicated for the treatment of opioid-induced constipation in adults.

Irritable Bowel Syndrome with Constipation: Lubilax is the only FDA approved drug for the treatment of irritable bowel syndrome with constipation in women >18 years old.

Precautions & Warnings

Chronic Idiopathic Constipation: Lubilax is indicated for the treatment of chronic idiopathic constipation in adults.

Opioid-induced Constipation: Lubilax is indicated for the treatment of opioid-induced constipation in adults.

Irritable Bowel Syndrome with Constipation: Lubilax is the only FDA approved drug for the treatment of irritable bowel syndrome with constipation in women >18 years old.

Pediatric Usage

Chronic Idiopathic Constipation: Lubilax is indicated for the treatment of chronic idiopathic constipation in adults.

Opioid-induced Constipation: Lubilax is indicated for the treatment of opioid-induced constipation in adults.

Irritable Bowel Syndrome with Constipation: Lubilax is the only FDA approved drug for the treatment of irritable bowel syndrome with constipation in women >18 years old.

Storage Conditions

Chronic Idiopathic Constipation: Lubilax is indicated for the treatment of chronic idiopathic constipation in adults.

Opioid-induced Constipation: Lubilax is indicated for the treatment of opioid-induced constipation in adults.

Irritable Bowel Syndrome with Constipation: Lubilax is the only FDA approved drug for the treatment of irritable bowel syndrome with constipation in women >18 years old.